The Impact of Prostate Imaging Reporting and Data System Version 2.1 and Prostate-Specific Antigen Density in the Prediction of Clinically Significant Prostate Cancer
Objective: The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and to determine whether applying Prostate Imaging Reporting and Data Systems version 2.1 score could improve the diagnostic pathway be...
Saved in:
| Published in: | Urology research and practice Vol. 49; no. 2; pp. 120 - 124 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Istanbul
Aves Yayincilik Ltd. STI
01.03.2023
Turkish Association of Urology |
| Subjects: | |
| ISSN: | 2980-1478, 2980-1478 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Objective: The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and to determine whether applying Prostate Imaging Reporting and Data Systems version 2.1 score could improve the diagnostic pathway besides the biochemical characteristics. Materials and methods: In this study, 199 patients with clinically suspected prostate cancer who underwent multiparametric magnetic resonance imaging were included. Logistic regression analyses and receiver operating characteristic curve were performed to determine independent predictors and to compare diagnostic performance of indicators for clinically significant prostate cancer. Two models were established. In model 1, the diagnostic performance of prostate-specific antigen- and prostatespecific antigen density-derived parameters were evaluated. In model 2, the prediction potential of model 1 plus Prostate Imaging Reporting and Data Systems version 2.1 score was analyzed. Results: Sixty-four patients were positive for clinically significant prostate cancer by histopathological analysis (32.1%). In model 1, a prostate-specific antigen density >0.15 was labeled as the strongest predictor of malignancy. In model 2, a prostatespecific antigen density >0.15, a Prostate Imaging Reporting and Data Systems score ≥3, and a Prostate Imaging Reporting and Data Systems score ≥4 demonstrated the strongest association with malignancy. Among these parameters, a Prostate Imaging Reporting and Data Systems score ≥4 (P=.003) was found to be the most robust predictor for malignancy, followed by a Prostate Imaging Reporting and Data Systems score ≥3 (P=.012). The multivariate analysis revealed higher accuracy in model 2 (76.9%) than in model 1 (67.8%). The area under curve values with respect to prostatespecific antigen, prostate-specific antigen density, model 1, and model 2 were 0.632, 0.741, 0.656, and 0.798, respectively. Conclusion: These results indicated that Prostate Imaging Reporting and Data Systems version 2.1 score and prostate-specific antigen density are independent predictors for the presence of clinically significant prostate cancer. Both prostate-specific antigen density and Prostate Imaging Reporting and Data Systems version 2.1 score should be risen to prominence in the decision of biopsy instead of PSA. |
|---|---|
| AbstractList | Objective: The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and to determine whether applying Prostate Imaging Reporting and Data Systems version 2.1 score could improve the diagnostic pathway besides the biochemical characteristics. Materials and methods: In this study, 199 patients with clinically suspected prostate cancer who underwent multiparametric magnetic resonance imaging were included. Logistic regression analyses and receiver operating characteristic curve were performed to determine independent predictors and to compare diagnostic performance of indicators for clinically significant prostate cancer. Two models were established. In model 1, the diagnostic performance of prostate-specific antigen- and prostatespecific antigen density-derived parameters were evaluated. In model 2, the prediction potential of model 1 plus Prostate Imaging Reporting and Data Systems version 2.1 score was analyzed. Results: Sixty-four patients were positive for clinically significant prostate cancer by histopathological analysis (32.1%). In model 1, a prostate-specific antigen density >0.15 was labeled as the strongest predictor of malignancy. In model 2, a prostatespecific antigen density >0.15, a Prostate Imaging Reporting and Data Systems score ≥3, and a Prostate Imaging Reporting and Data Systems score ≥4 demonstrated the strongest association with malignancy. Among these parameters, a Prostate Imaging Reporting and Data Systems score ≥4 (P=.003) was found to be the most robust predictor for malignancy, followed by a Prostate Imaging Reporting and Data Systems score ≥3 (P=.012). The multivariate analysis revealed higher accuracy in model 2 (76.9%) than in model 1 (67.8%). The area under curve values with respect to prostatespecific antigen, prostate-specific antigen density, model 1, and model 2 were 0.632, 0.741, 0.656, and 0.798, respectively. Conclusion: These results indicated that Prostate Imaging Reporting and Data Systems version 2.1 score and prostate-specific antigen density are independent predictors for the presence of clinically significant prostate cancer. Both prostate-specific antigen density and Prostate Imaging Reporting and Data Systems version 2.1 score should be risen to prominence in the decision of biopsy instead of PSA. The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and to determine whether applying Prostate Imaging Reporting and Data Systems version 2.1 score could improve the diagnostic pathway besides the biochemical characteristics.OBJECTIVEThe aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and to determine whether applying Prostate Imaging Reporting and Data Systems version 2.1 score could improve the diagnostic pathway besides the biochemical characteristics.In this study, 199 patients with clinically suspected prostate cancer who underwent multiparametric magnetic resonance imaging were included. Logistic regression analyses and receiver operating characteristic curve were performed to determine independent predictors and to compare diagnostic performance of indicators for clinically significant prostate cancer. Two models were established. In model 1, the diagnostic performance of prostate-specific antigen- and prostatespecific antigen density-derived parameters were evaluated. In model 2, the prediction potential of model 1 plus Prostate Imaging Reporting and Data Systems version 2.1 score was analyzed.MATERIALS AND METHODSIn this study, 199 patients with clinically suspected prostate cancer who underwent multiparametric magnetic resonance imaging were included. Logistic regression analyses and receiver operating characteristic curve were performed to determine independent predictors and to compare diagnostic performance of indicators for clinically significant prostate cancer. Two models were established. In model 1, the diagnostic performance of prostate-specific antigen- and prostatespecific antigen density-derived parameters were evaluated. In model 2, the prediction potential of model 1 plus Prostate Imaging Reporting and Data Systems version 2.1 score was analyzed.Sixty-four patients were positive for clinically significant prostate cancer by histopathological analysis (32.1%). In model 1, a prostate-specific antigen density >0.15 was labeled as the strongest predictor of malignancy. In model 2, a prostatespecific antigen density >0.15, a Prostate Imaging Reporting and Data Systems score ≥3, and a Prostate Imaging Reporting and Data Systems score ≥4 demonstrated the strongest association with malignancy. Among these parameters, a Prostate Imaging Reporting and Data Systems score ≥4 (P=.003) was found to be the most robust predictor for malignancy, followed by a Prostate Imaging Reporting and Data Systems score ≥3 (P=.012). The multivariate analysis revealed higher accuracy in model 2 (76.9%) than in model 1 (67.8%). The area under curve values with respect to prostatespecific antigen, prostate-specific antigen density, model 1, and model 2 were 0.632, 0.741, 0.656, and 0.798, respectively.RESULTSSixty-four patients were positive for clinically significant prostate cancer by histopathological analysis (32.1%). In model 1, a prostate-specific antigen density >0.15 was labeled as the strongest predictor of malignancy. In model 2, a prostatespecific antigen density >0.15, a Prostate Imaging Reporting and Data Systems score ≥3, and a Prostate Imaging Reporting and Data Systems score ≥4 demonstrated the strongest association with malignancy. Among these parameters, a Prostate Imaging Reporting and Data Systems score ≥4 (P=.003) was found to be the most robust predictor for malignancy, followed by a Prostate Imaging Reporting and Data Systems score ≥3 (P=.012). The multivariate analysis revealed higher accuracy in model 2 (76.9%) than in model 1 (67.8%). The area under curve values with respect to prostatespecific antigen, prostate-specific antigen density, model 1, and model 2 were 0.632, 0.741, 0.656, and 0.798, respectively.These results indicated that Prostate Imaging Reporting and Data Systems version 2.1 score and prostate-specific antigen density are independent predictors for the presence of clinically significant prostate cancer. Both prostate-specific antigen density and Prostate Imaging Reporting and Data Systems version 2.1 score should be risen to prominence in the decision of biopsy instead of PSA.CONCLUSIONThese results indicated that Prostate Imaging Reporting and Data Systems version 2.1 score and prostate-specific antigen density are independent predictors for the presence of clinically significant prostate cancer. Both prostate-specific antigen density and Prostate Imaging Reporting and Data Systems version 2.1 score should be risen to prominence in the decision of biopsy instead of PSA. |
| Author | Funda Ulu Ozturk Ozturk, Erdem Bekar, Ulku Tezcan, Sehnaz |
| Author_xml | – sequence: 1 givenname: Sehnaz surname: Tezcan fullname: Tezcan, Sehnaz – sequence: 2 fullname: Funda Ulu Ozturk – sequence: 3 givenname: Ulku surname: Bekar fullname: Bekar, Ulku – sequence: 4 givenname: Erdem surname: Ozturk fullname: Ozturk, Erdem |
| BookMark | eNpdUEtv1DAQtlCRKKVnrpa4cMliO3Fin1C1LVCpEhVbuEbeyWzqKhkH20HaP8TvJIEiHqcZzfeamefshAIhYy-l2Gip1Zs8dxslVLlRSkhrn7BTZY0oZNWYk7_6Z-w8pQchhDKNsqI5Zd_v7pFfj5ODzMOB38aQssvryPWeev4JpxDz2jnq-KXLju-OKePIv2BMPhBXG_kT-y0tdhOCP3jgF5R9j8QvkZLPR-6J5yXtNmLnIa_aJXE7ePLghuHId76nVego_1lk6wgwvmBPD25IeP5Yz9jnd1d32w_Fzcf319uLmwJKa3PRQGfAgAWpdS1kJfa6qhq0rgMJJTZ1Ja2WrpZd1e0F7ms8KKmlcDWgLA2UZ-ztL99p3o_YAVKObmin6EcXj21wvv0XIX_f9uFbK5e3q8boxeH1o0MMX2dMuR19AhwGRxjm1CpjZLOyy4X66j_qQ5gjLfctLFEbKWotyh_X3ZeB |
| CitedBy_id | crossref_primary_10_3389_fonc_2024_1467793 |
| ContentType | Journal Article |
| Copyright | 2023. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://turkishjournalofurology.com/en/copyright-1011 2023 authors 2023 authors |
| Copyright_xml | – notice: 2023. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://turkishjournalofurology.com/en/copyright-1011 – notice: 2023 authors 2023 authors |
| DBID | 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO EDSIH FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.5152/tud.2023.220199 |
| DatabaseName | ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Turkey Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Turkey Database ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2980-1478 |
| EndPage | 124 |
| ExternalDocumentID | PMC10192785 |
| GroupedDBID | 3V. 7X7 7XB 8FI 8FJ 8FK ABDBF ABUWG AFFHD AFKRA ALMA_UNASSIGNED_HOLDINGS AZQEC BENPR CCPQU DWQXO EDSIH EOJEC ESX FYUFA GROUPED_DOAJ HMCUK K9. OBODZ PGMZT PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS RPM TUS UKHRP 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c399t-7cd8c8c9c15560140b5447e9adc1c3e7641951a61d4db0eb6ef21510a6ce138c3 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001002995800008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2980-1478 |
| IngestDate | Tue Nov 04 02:07:38 EST 2025 Thu Sep 04 18:45:00 EDT 2025 Sat Nov 29 14:26:11 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c399t-7cd8c8c9c15560140b5447e9adc1c3e7641951a61d4db0eb6ef21510a6ce138c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Cite this article as: Tezcan S, Ulu Ozturk F, Bekar U, Ozturk E. The impact of prostate imaging reporting and data system version 2.1 and prostate-specific antigen density in the prediction of clinically significant prostate cancer. Urol Res Pract., 2023;49(2):120-124. |
| ORCID | 0000-0001-7204-3008 0000-0003-2782-2824 0000-0001-6963-2880 0000-0002-2360-788X |
| OpenAccessLink | https://www.proquest.com/docview/2806810650?pq-origsite=%requestingapplication% |
| PQID | 2806810650 |
| PQPubID | 106063 |
| PageCount | 5 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10192785 proquest_miscellaneous_2881710193 proquest_journals_2806810650 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-03-01 |
| PublicationDateYYYYMMDD | 2023-03-01 |
| PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Istanbul |
| PublicationPlace_xml | – name: Istanbul |
| PublicationTitle | Urology research and practice |
| PublicationYear | 2023 |
| Publisher | Aves Yayincilik Ltd. STI Turkish Association of Urology |
| Publisher_xml | – name: Aves Yayincilik Ltd. STI – name: Turkish Association of Urology |
| SSID | ssj0002872907 |
| Score | 2.2189739 |
| Snippet | Objective: The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate... The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and... |
| SourceID | pubmedcentral proquest |
| SourceType | Open Access Repository Aggregation Database |
| StartPage | 120 |
| SubjectTerms | Antigens Clinical significance Magnetic resonance imaging Original Prostate cancer Urology Urooncology |
| Title | The Impact of Prostate Imaging Reporting and Data System Version 2.1 and Prostate-Specific Antigen Density in the Prediction of Clinically Significant Prostate Cancer |
| URI | https://www.proquest.com/docview/2806810650 https://www.proquest.com/docview/2881710193 https://pubmed.ncbi.nlm.nih.gov/PMC10192785 |
| Volume | 49 |
| WOSCitedRecordID | wos001002995800008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2980-1478 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002872907 issn: 2980-1478 databaseCode: DOA dateStart: 20220101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: AUTh Library subscriptions: ProQuest Central customDbUrl: eissn: 2980-1478 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002872907 issn: 2980-1478 databaseCode: BENPR dateStart: 20090301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2980-1478 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002872907 issn: 2980-1478 databaseCode: 7X7 dateStart: 20090301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2980-1478 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002872907 issn: 2980-1478 databaseCode: PIMPY dateStart: 20090301 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Turkey Database customDbUrl: eissn: 2980-1478 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002872907 issn: 2980-1478 databaseCode: EDSIH dateStart: 20090301 isFulltext: true titleUrlDefault: https://search.proquest.com/turkey providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NT8MgFCe6efDiR9Q4nQsmXlHpOqAnMzeNHlwaP5J5WoAybWI63TqT_UP-nb5HO-cuXrw0bYFA4MH7PXj8HiEnkTBOtqxgXAvLQqU5iwBmsIAbaa0IW04rH2xC9nqq34_icsNtUrpVztdEv1AnI4t75Gd4Aqg4AoqL9w-GUaPwdLUMobFKqhg2G-Vc9uXPHgtYAwEYfwWjDyju4CyfIjto0DwNQPFFy7By2Snyl5a53vxv-7bIRokvabsQiG2yko93yBcIA7319yHpaEhjvOkBGBN--RhFtEDh-KazhHZ1rmnBZE7L7TQanHKfNi_KfNz6YWppO8uR0JN20RM-n9E0o4ApISOeAOGoY40l--jb24w-pC8ZFoQRXTSkg7I33iVP11ePnRtWBmhgFnBNziQSCygbWQAlAk010wpD6SKdWG6bToqQA4DTgidhYs6dEW6ICOMcxMLxprLNPVLJRpnbJ3QIMNJo45xVYOIFIgJc5ERojUEN6lyN1OfdPihn2WSw6PMaOf5JhvmBhx46c6Mp5lEcUBTg1BpRSyM8eC_4PAbIsL2ckqWvnmkbywVStQ7-rv2QrKNQFa5pdVLJx1N3RNbsZ55Oxg0vk_6pGqR6edWL7xve9Iev-PYufv4GKez2Iw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VgkQvPASIQAtGgqPb2tnY3gOqqoaqUUtUqUXKbbG9Exqp2oRkA8of4shvZGYfLblw64Hbam3vwx7PfON5AbxPTUDbi0Yqb6JMnFcyJZghtQo2RpP00Luq2IQdDt1olJ5vwO82FobdKlueWDHqfBr5jHyPLYBOMaA4mH2XXDWKrattCY2aLE5x9ZNUtsXHQZ_W94PWx58uj05kU1VARhLGpbQcDe9iGkmSGtYvQi9JLKY-jyp20ZpEEerwRuVJHvYxGByzWNynf0HVdbFLz70H94mPW1b27MjenOmQ9qFJ2awzCBFQ0HvlkrOR6u6uJkGbrsPYdSfMv6Ta8eP_bT6ewKMGP4vDmuCfwkY5fwa_iNjFoIr3FNOxOOdIFsLQdKuqwSRqLYOvfJGLvi-9qDO1i-a4UOhdVbW1Q-XFDCtvRXFYlJywVPTZ079ciUkhCDNTR7ZwMVXzG5vsqtfXK3Ex-VbwQKLY2w854r01fw5f7mRqXsBmMS3wJYgxweTgA2J0pMJqkxLuQ5PEEBghIHZgu13mrOEii-x2jTvw7qaZ9j8bdXyB0yX3cYpQIuHwDrg1ispmdb6SjDOIr7cUk6sqkziP09b1Xv377W_h4cnl57PsbDA8fQ1bTNC1G942bJbzJe7Ag_ijnCzmb6r9IODrXRPcH4rCTZM |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VFCEuPASogUKNBEc3tbPxeg8IVQ0RUSFaqSCV02J7JxCp2oRkA8of4kfw65jZR9tcuPXAbbW292HPeL7xvABeJcZjPAhGKmeCjKxTMiGYIbXycQgmGqCzVbGJeDKx5-dJugN_2lgYdqts98Rqo87ngc_Ie2wBtIoBRW_auEWkw9HbxQ_JFaTY0tqW06hJ5BQ3v0h9W70ZD2mtX2s9evfp5L1sKgzIQIK5lDFHxtuQBJKqhnUNP4iiGBOXBxX6GJtIEQJxRuVR7o_QG5yyiDyi_0LVt6FPz70FuwTJI92B3XT8Mf1yecJDuogm1bPOJ0SwQffKNecm1f1DTWI32Qa12y6Z12Tc6P7_PDsP4F6DrMVxzQoPYadcPoLfxAZiXEWCivlUpBzjQuiablXVmUStf_CVK3IxdKUTdQ530RwkCn2oqrZ2qDxbYOXHKI6LklOZiiHHAJQbMSsEoWnqyLYvpnd-Y5N39eJiI85m3woeSLR89SEnzHXLx_D5RqbmCXSKeYF7IKYEoL3ziMGScqtNQogQTRS8Z-yA2IX9dsmzZn9ZZVfr3YWXl820M7C5xxU4X3Mfqwg_EkLvgt2irmxRZzLJOLf4dksx-17lGOdxOraDp_9--wHcITrLPownp8_gLtN27Z-3D51yucbncDv8LGer5YuGOQR8vWmK-wuD2lfi |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+Prostate+Imaging+Reporting+and+Data+System+Version+2.1+and+Prostate-Specific+Antigen+Density+in+the+Prediction+of+Clinically+Significant+Prostate+Cancer&rft.jtitle=Urology+research+and+practice&rft.au=Tezcan%2C+Sehnaz&rft.au=Funda+Ulu+Ozturk&rft.au=Bekar%2C+Ulku&rft.au=Ozturk%2C+Erdem&rft.date=2023-03-01&rft.pub=Aves+Yayincilik+Ltd.+STI&rft.eissn=2980-1478&rft.volume=49&rft.issue=2&rft.spage=120&rft_id=info:doi/10.5152%2Ftud.2023.220199&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2980-1478&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2980-1478&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2980-1478&client=summon |